Skip to main content

CJC-1295 vs Ipamorelin vs Mod GRF 1-29

A three-way comparison to help you find the right peptide for your research goals.

CJC-1295

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce more growth hormone.

Full details →

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that stimulates the release of growth hormone from the pituitary gland without significantly affecting cortisol or prolactin.

Full details →

Mod GRF 1-29

Mod GRF 1-29 (Modified GRF 1-29, also called CJC-1295 without DAC or Tetrasubstituted GRF 1-29) is a modified growth hormone-releasing hormone analog with improved stability over natural GHRH.

Full details →

Side-by-Side Comparison

AspectCJC-1295IpamorelinMod GRF 1-29
MechanismCJC-1295 binds to GHRH receptors in the pituitary, triggering increased production and release of growth hormone. The DAC (Drug Affinity Complex) version extends half-life significantly.Acts as a ghrelin mimetic, binding to the ghrelin receptor (GHS-R) in the pituitary to stimulate GH release. Highly selective with minimal effect on other hormones.Binds to GHRH receptors in the pituitary gland to stimulate growth hormone release. Four amino acid substitutions improve resistance to enzymatic degradation while maintaining biological activity.
Typical DosageCJC-1295 DAC: 1-2mg weekly. CJC-1295 no DAC (Mod GRF 1-29): 100-300mcg 2-3 times daily.Typical dosing ranges from 200-300mcg administered 2-3 times daily, often combined with CJC-1295.Typical dosing: 100-300mcg administered 2-3 times daily, usually combined with a GHRP like Ipamorelin for synergistic effects.
AdministrationSubcutaneous injection, often combined with a GHRP like Ipamorelin for synergistic effects. Best administered before sleep or fasted.Subcutaneous injection. Best results when administered fasted or before sleep. Often stacked with GHRH peptides.Subcutaneous injection. Best administered on empty stomach. Short half-life (~30 minutes) necessitates multiple daily doses, unlike DAC version.
Side EffectsWater retention, tingling in extremities, potential increase in cortisol and prolactin levels.Generally well-tolerated. May cause mild headaches, lightheadedness, or increased hunger initially.Flushing, headache, dizziness, and injection site reactions. Generally well-tolerated. May cause water retention.
Best For

What They Have in Common

CJC-1295, Ipamorelin, Mod GRF 1-29 are all commonly used for:

Key Differences

Unique to Ipamorelin:

Unique to Mod GRF 1-29:

Detailed Analysis

Commonalities

Both CJC-1295 and Ipamorelin are commonly used for Muscle Growth, Fat Loss, Sleep Quality.

Which Should You Choose?

Ipamorelin has stronger evidence for Sleep Quality.

Commonalities

Both CJC-1295 and Mod GRF 1-29 are commonly used for Muscle Growth, Fat Loss, Sleep Quality.

Which Should You Choose?

CJC-1295 has stronger evidence for Fat Loss.

Commonalities

Both Ipamorelin and Mod GRF 1-29 are commonly used for Muscle Growth, Fat Loss, Recovery & Healing, Sleep Quality.

Which Should You Choose?

Ipamorelin has stronger evidence for Fat Loss, Sleep Quality.

Ready to Learn More?